BANK OF AMERICA CORP /DE/ (BAC) vs PFIZER INC(PFE)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | BAC | PFE |
|---|---|---|
| Sector | Financials | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $113.10B | $62.58B |
| Revenue growth (YoY) | ▲ 11.0% | ▼ 1.6% |
| Net income | $30.51B | $7.81B |
| Gross margin | — | — |
| Diluted EPS | $3.81 | $1.36 |
| Insider net (6 mo) | −532.7K sh · 37 sells · 31 buys | +130.5K sh · 2 sells · 3 buys |
| Institutional owners | 51 | 44 |
| Institutional value held | $180.93B | $61.93B |
| Next earnings (est.) | Oct 14, 2026 | Nov 3, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About BANK OF AMERICA CORP /DE/ (BAC)
Bank of America Corporation, a Delaware-incorporated bank holding company (BHC) and financial holding company headquartered in Charlotte, North Carolina, is one of the world's largest financial institutions, serving individual consumers, small- and middle-mark
About PFIZER INC (PFE)
Pfizer Inc. is a research-based, global biopharmaceutical company incorporated in Delaware in 1942 that applies science and global resources to discover, develop, manufacture, market, sell and distribute biopharmaceutical products worldwide, operating across b
Source: SEC EDGAR.